Major firms forecast to suffer poor Q1 results

Seven major pharmaceutical companies are likely to see their first-quarter earnings worsen with operating and net profits falling 40 percent and 34 percent, respectively buffeted by stubbornly weak domestic demand, according to Yakup Shinmoon.

But, by many aspects, they have fared relatively well even in the midst of tough regulations and intense competition at home, except for Green Cross C...